The effect of acute application of pegvisomant alone and in combination with 
octreotide on endogenous GH levels during a 6-h test in patients with 
acromegaly on constant pegvisomant treatment

Roemmler, J.; Steffin, B.; Gutt, B.; Sievers, C.; Bidlingmaier, M.; Schopohl, J.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatment

MPS-Authors

/persons/resource/persons80528

Sievers, C.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Roemmler, J., Steffin, B., Gutt, B., Sievers, C., Bidlingmaier, M., & Schopohl, J. (2009). The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatment. Growth Hormone & IGF Research, 19(3), 245-251.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-928F-A

Abstract

There is no abstract available